Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis

BACKGROUND: Up to 5% of familial Mediterranean fever (FMF) cases are unresponsive to colchicine, through resistance, side effects and toxicity. Anakinra is an alternative treatment for FMF patients whose disease remains uncontrolled with colchicine. We aimed to evaluate anti-interleukin-1 treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Sargin, Gokhan, Kose, Reyhan, Senturk, Taskin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Paulista de Medicina - APM 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721218/
https://www.ncbi.nlm.nih.gov/pubmed/31116269
http://dx.doi.org/10.1590/1516-3180.2018.0311101218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721218/
https://www.ncbi.nlm.nih.gov/pubmed/31116269
http://dx.doi.org/10.1590/1516-3180.2018.0311101218

Ejemplares similares